Screening compound: InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H

Screening compound: InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H
Screening compound: InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L109-0543

Molecular Formula

C16H8ClF3N4O2 (C16 H8 ClF3 N4 O2)

Compound Name

1-(3-chloro-4-fluorophenyl)-5-(3,4-difluorophenyl)-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazole-4,6-dione

IUPAC name

1-(3-chloro-4-fluorophenyl)-5-(34-difluorophenyl)-1H3aH4H5H6H6aH-pyrrolo[34-d][123]triazole-46-dione

SMILES

O=C(C1N(c(cc2)cc(Cl)c2F)N=NC1C1=O)N1c(cc1)cc(F)c1F

MDL Number (MFCD)

InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
Targets:
  • Proteases
  • Others
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H?
Check Price and Availability of InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C16H8ClF3N4O2/c17-9-5-8(2-3-10(9)18)24-14-13(21-22-24)15(25)23(16(14)26)7-1-4-11(19)12(20)6-7/h1-6,13-14H available by request